These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Glanzmann's thrombasthenia: meeting the anticoagulation challenge. Binder A, Aledort L. Haemophilia; 2015 Jul; 21(4):e322-3. PubMed ID: 25939445 [No Abstract] [Full Text] [Related]
26. Difficulty in controlling heavy menstrual bleeding at menarche in a patient with Glanzmann's thrombasthenia. Kadowaki S, Makino S, Mohri Y, Awaguni H, Shinozuka J, Imashuku S. Blood Coagul Fibrinolysis; 2021 Mar 01; 32(2):155-158. PubMed ID: 33196513 [Abstract] [Full Text] [Related]
27. [Activated Factor VII - 31 years experience on clinical grounds]. Udvardy M. Orv Hetil; 2017 Jun 01; 158(24):923-928. PubMed ID: 28604077 [Abstract] [Full Text] [Related]
28. Perioperative management of Glanzmann's syndrome: how we did it! Depner C, Schmid R, Kirchhoff P, Oertli D. Blood Coagul Fibrinolysis; 2010 Apr 01; 21(3):283-4. PubMed ID: 20182353 [Abstract] [Full Text] [Related]
29. Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa. Javed A, Ayyub M, Abrar S, Mansoor M, Khan B, Hussain T. J Ayub Med Coll Abbottabad; 2009 Apr 01; 21(2):171-3. PubMed ID: 20524499 [Abstract] [Full Text] [Related]
34. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia. Cağlar K, Cetinkaya A, Aytaç S, Gümrük F, Gürgey A. Pediatr Hematol Oncol; 2003 Sep 01; 20(6):435-8. PubMed ID: 14631616 [Abstract] [Full Text] [Related]
35. Congenital and acquired platelet disorders: current dilemmas and treatment strategies. White GC. Semin Hematol; 2006 Jan 01; 43(1 Suppl 1):S37-41. PubMed ID: 16427384 [Abstract] [Full Text] [Related]
36. Intensive menstrual bleeding successfully treated with recombinant factor VIIa in Glanzmann thrombasthenia. Balci YI, Karabulut A, Kabukcu S, Sari I, Keskin A. Clin Appl Thromb Hemost; 2011 Aug 01; 17(4):320-2. PubMed ID: 20460355 [Abstract] [Full Text] [Related]
37. Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia. Poon MC, d'Oiron R, Hann I, Négrier C, de Lumley L, Thomas A, Karafoulidou A, Demers C, Street A, Huth-Kühne A, Petrini P, Fressinaud E, Morfini M, Tengborn L, Marquès-Verdier A, Musso R, Devecioglu O, Houston DS, Lethagen S, Van Geet C, von Depka M, Berger C, Beurrier P, Britton HA, Gerrits W, Guthner C, Kuhle S, Lorenzo JJ, Makris PE, Nohe N, Paugy P, Pautard B, Torchet MF, Trillot N, Vicariot M, Wilde J, Winter M, Chambost H, Ingerslev J, Peters M, Strauss G. Semin Hematol; 2001 Oct 01; 38(4 Suppl 12):21-5. PubMed ID: 11735106 [Abstract] [Full Text] [Related]
38. Recombinant activated factor VII combined with desmopressin in preventing bleeding from dental extraction in a patient with Glanzmann's thrombasthenia. Lombardo VT, Sottilotta G. Clin Appl Thromb Hemost; 2006 Jan 01; 12(1):115-6. PubMed ID: 16444446 [Abstract] [Full Text] [Related]
39. Traumatic haemorrhage: a role for recombinant factor VIIa? Spivey MH, Duffy MR. Anaesthesia; 2009 Oct 01; 64(10):1141-2. PubMed ID: 19735409 [No Abstract] [Full Text] [Related]
40. A chamber of hope for hemophilia. Pipe SW, Kaufman RJ. Nat Biotechnol; 2000 Mar 01; 18(3):264-5. PubMed ID: 10700134 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]